HOUSTON (May 12, 2015) – OrthoAccel® Technologies, Inc. today announced that Len Hedge, a retired Align Technology senior executive, has joined OrthoAccel’s board of directors. The leader in accelerated orthodontics, OrthoAccel develops and manufactures AcceleDent®, the first and only FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent.
Hedge currently serves on the boards of directors for two additional dental companies, Convergent Dental, Inc. and MicroDental Laboratories. His in depth experience in the orthodontic industry includes a 14-year career at Align Technology where he served in various roles including senior vice president of business operations, vice president of operations and vice president of manufacturing.
“We’re fortunate to have Len Hedge as a new member of the OrthoAccel board. His strategic business foresight and expertise in manufacturing is particularly valuable as we continue to bring innovation to the orthodontic industry,” said Michael K. Lowe, president and CEO of OrthoAccel. “Len has demonstrated success and proven results time and time again in high-growth, technology-intensive markets, and we know he will bring that same vision, passion and commitment to OrthoAccel.”
Hedge joins OrthoAccel as AcceleDent’s momentum continues to grow. The technology is now offered in more than 2,300 orthodontic locations in the U.S. and Canada. The only fast, safe and gentle solution to accelerating orthodontic treatment, AcceleDent continues to receive high patient satisfaction reviews and, according to the Journal of Clinical Orthodontics, AcceleDent is the most common accelerated treatment technique used by orthodontists.
“Having watched OrthoAccel’s rapid growth, specifically with AcceleDent, I’m honored to now be a part of the company’s exciting future,” said Hedge. “The path of innovation that OrthoAccel has forged for the accelerated orthodontic industry is groundbreaking, and this medical device company has positioned itself to spur even greater innovation all around for the orthodontic and dental industries.”
In addition to Lowe and Hedge, OrthoAccel’s board of directors is comprised of Todd Cooper, president and CEO of Presbia PLC; John C. McCormick, managing director and senior member of HealthpointCapital’s research and investment team; and Brian Smith, managing director of S3 Ventures.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and sells AcceleDent®, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at acceledent.com and acceledent.co.uk or requested via firstname.lastname@example.org.